Amy Holder

Amy Holder supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in managing critical procurement activities that enable public health readiness and scientific response. She oversees the acquisition of laboratory diagnostics, biomedical research tools, and data infrastructure essential to disease surveillance and outbreak response. Her work directly advances CDC’s mission by ensuring timely access to high-capacity testing platforms, clinical analytics software, and operational support services that underpin national health security efforts. She typically handles complex, mission-critical contracts under FAR Part 15, with a focus on performance-based requirements and long-term service delivery models. Holder maintains established relationships with leading providers in public health technology and diagnostics, including General Dynamics Information Technology, Cepheid, MRIGLOBAL, GlaxoSmithKline, and New York City Health & Hospitals Corp. These partnerships reflect a strategic emphasis on scalable, validated solutions for infectious disease detection, laboratory automation, and epidemiological data systems. Her contracting approach prioritizes vendors with proven expertise in regulatory compliance, CLIA-certified testing environments, and FDA-cleared diagnostic platforms, fostering collaborative, performance-driven vendor relationships grounded in technical rigor and operational reliability. A strong advocate for small business participation, Holder consistently applies a 75% total small business set-aside preference across her acquisition portfolio, aligning with FAR 19.5 to maximize opportunities for small disadvantaged, woman-owned, and HUBZone firms. This pattern underscores a deliberate commitment to socioeconomic equity and workforce development within the public health supply chain, ensuring diverse vendors contribute to mission-critical capabilities while building long-term capacity in underserved markets. Her primary procurement focus lies in NAICS 621511 (Medical Laboratories), where she acquires clinical testing services, reference lab support, and diagnostic assay validation. She also engages NAICS 513210 (Software Publishers) to procure specialized public health analytics platforms, data integration tools, and real-time surveillance systems. Her technical domain expertise centers on molecular diagnostics, laboratory information management systems (LIMS), and interoperable health data architectures that support rapid, evidence-based public health decision-making.